Targeting ADAM17 to dampen dendritic cell-mediated type 2 immune responses and airway inflammation associated with allergic asthma. - Jaiswal, Anil Kumar; Minond, Dmitriy; Mishra, Amarjit (Scientific Reports, 2025)